403 results on '"Eriksson, Urs"'
Search Results
2. Herzmuskelerkrankungen
3. (Peri-)Myocarditis
4. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis – Central role of macrophage scavenger receptor 1
5. Requirement of JNK2 for Scavenger Receptor A: Mediated Foam Cell Formation in Atherogenesis
6. Gender-specific differences in comorbidities, in-hospital complications and outcomes in emergency patients with ethanol intoxication with and without multisubstance use
7. Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis
8. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice—an underestimated complication?
9. Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting
10. Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting
11. Autoimmune Heart Disease: Animal Models
12. Herzmuskelerkrankungen
13. Distinctive characteristics of His bundle potentials in patients with atrioventricular nodal reentrant tachycardia.
14. Myocarditis followingCOVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
15. Cardiac resynchronization therapy in the presence of total atrioventricular block reduces long‐lasting atrial fibrillation episodes
16. The Role of IL-17 in Experimental Autoimmune Myocarditis
17. Transesophageal Echocardiography-Guided Transseptal Left Atrial Access to Improve Safety in Patients Undergoing Pulmonary Vein Isolation
18. Autoimmune Murine Myocarditis and Immunomodulatory Interventions
19. The role of IL-17 in experimental autoimmune myocarditis
20. Microvesicles released from activated CD4+T cells alter microvascular endothelial cell function
21. Angiotensin II receptor 1 controls profibrotic Wnt/β-catenin signalling in experimentalautoimmune myocarditis
22. Microvesicles released from activated $CD4^{\text{+}}$ T cells alter microvascular endothelial cell function
23. Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
24. The Increasing Investment of Real Estate in the Health System—A Comparison between the USA and Europe
25. Distinctive characteristics of his bundle potentials in patients with atrioventricular nodal reentrant tachycardia
26. High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry
27. B-PO02-180 HIGH BURDEN OF INAPPROPRIATE ALARMS BY THE WEARABLE CARDIOVERTER-DEFIBRILLATOR IN OBESE PATIENTS - FINDINGS FROM THE SWISS WCD REGISTRY
28. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity
29. Comparison Of Effects Of Amphotericin B Deoxycholate Infused Over 4 Or 24 Hours: Randomised Controlled Trial
30. Mild endothelial dysfunction in Sirt3 knockout mice fed a high-cholesterol diet: protective role of a novel C/EBP-β-dependent feedback regulation of SOD2
31. Mechanisms of Cardiac Fibrosis in Inflammatory Heart Disease
32. Mononuclear cell secretome protects from experimental autoimmune myocarditis
33. Microvesicles released from activated CD4+ T cells alter microvascular endothelial cell function.
34. Gene expression profiling: time to file diagnostic uncertainty in inflammatory heart diseases?
35. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
36. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
37. Angiotensin II receptor 1 controls profibrotic Wnt/β-catenin signalling in experimental autoimmune myocarditis
38. Effusive-Constrictive Pericarditis due to Immune Reconstitution Inflammatory Syndrome following Tuberculous Pericarditis
39. Factors that trigger emergency physicians to contact a poison centre: findings from a Swiss study
40. Sudden death after open gastric bypass surgery
41. Angiotensin II receptor 1 controls profibrotic Wnt/β-catenin signalling in experimental autoimmune myocarditis.
42. Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury
43. Recurrent syncope after a finger injury and induced monomorphic ventricular tachycardia: Really Brugada syndrome?
44. Incidence, risk factors, and outcome of aspiration pneumonitis in ICU overdose patients
45. The Role of IL-17 in Experimental Autoimmune Myocarditis
46. The adaptor protein c-Cbl-associated protein (CAP) limits pro-inflammatory cytokine expression by inhibiting the NF-κB pathway
47. Distinct functions of junD in cardiac hypertrophy and heart failure
48. A story of two ACEs
49. Isolated persistent left superior vena cava draining into the left atrium of an otherwise normal heart
50. Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.